Northern Trust Corp increased its stake in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) by 11.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 478,907 shares of the company's stock after purchasing an additional 48,572 shares during the period. Northern Trust Corp owned 0.25% of Aveanna Healthcare worth $2,189,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. KLP Kapitalforvaltning AS acquired a new stake in Aveanna Healthcare during the 4th quarter worth $35,000. Tower Research Capital LLC TRC grew its position in shares of Aveanna Healthcare by 662.2% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company's stock valued at $36,000 after purchasing an additional 6,854 shares in the last quarter. Catalyst Funds Management Pty Ltd increased its holdings in shares of Aveanna Healthcare by 321.4% in the fourth quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company's stock valued at $54,000 after purchasing an additional 9,000 shares during the last quarter. Sagespring Wealth Partners LLC purchased a new position in Aveanna Healthcare during the fourth quarter worth approximately $57,000. Finally, Walleye Capital LLC acquired a new position in Aveanna Healthcare during the fourth quarter worth $64,000. 87.96% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several research analysts have recently weighed in on AVAH shares. Truist Financial lowered their price target on shares of Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating on the stock in a research report on Friday, April 11th. UBS Group upped their price objective on Aveanna Healthcare from $4.50 to $5.00 and gave the company a "sell" rating in a report on Friday, May 9th.
Read Our Latest Stock Analysis on AVAH
Insider Buying and Selling at Aveanna Healthcare
In other Aveanna Healthcare news, major shareholder Robert M. Williams, Jr. sold 91,061 shares of the company's stock in a transaction dated Thursday, May 8th. The shares were sold at an average price of $5.84, for a total value of $531,796.24. Following the completion of the transaction, the insider now directly owns 545,330 shares of the company's stock, valued at $3,184,727.20. This represents a 14.31% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, major shareholder J.H. Whitney Equity Partners V sold 1,560,700 shares of the company's stock in a transaction that occurred on Monday, May 19th. The shares were sold at an average price of $5.36, for a total value of $8,365,352.00. Following the sale, the insider now directly owns 29,640,756 shares in the company, valued at approximately $158,874,452.16. This represents a 5.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 4,887,612 shares of company stock worth $26,269,057 in the last 90 days. 7.80% of the stock is owned by company insiders.
Aveanna Healthcare Price Performance
Shares of AVAH stock traded up $0.08 during mid-day trading on Friday, hitting $5.33. The stock had a trading volume of 28,995 shares, compared to its average volume of 301,626. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $2.32 and a fifty-two week high of $6.19. The company's 50-day simple moving average is $5.08 and its 200-day simple moving average is $4.95. The firm has a market cap of $1.04 billion, a PE ratio of -15.62 and a beta of 2.01.
Aveanna Healthcare Profile
(
Free Report)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
See Also

Before you consider Aveanna Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.
While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.